Researchers Identify the Critical Gap in Colorectal Cancer Screening
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
Geneoscopy’s multi-target stool RNA (mt-sRNA) biomarker panel is designed to detect precancerous lesions and colorectal cancer.
CVS Pharmacy has begun in-store sales rollout of Biomerica's EZ Detect colorectal disease screening test in over 7,000 stores nationwide.
xT CDx is a 648-gene next-generation sequencing test for solid tumor profiling, which includes microsatellite instability status and companion diagnostic claims for colorectal cancer patients.
Read MoreEarlySign ColonFlag will now be offered within the navify Algorithm Suite from Roche Diagnostics to improve early detection of colon cancer.
Read MoreBeacon Biomedical announced the availability of its BeScreened Colorectal Cancer (CRC) test at Any Lab Test Now locations across the nation.
Read MoreA new report shows Saudi Arabia has a high percentage of respondents who never took colon cancer tests, far higher than the global average.
Read MoreBeacon Biomedical released a colon cancer screening test designed to improve access and affordability to CRC screening as a blood draw.
Read MoreGuardant Health and Ohio State University will evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening.
Read MoreGuardant Health submitted the final module of its premarket approval application for a colon cancer screening blood test to the FDA.
Read MoreSonora Quest Laboratories is now offering its first home screening kits available through their self-order service, My Lab ReQuest.
Read MoreMany people don’t undergo recommended screening for colorectal cancer, despite availability of at-home stool fecal immunochemical test kits.
Read MoreGeneoscopy submitted a Premarket Approval application to the FDA for its noninvasive, at-home screening test to detect colorectal cancer.
Read MoreHelio Genomics unveiled positive finds of its multimodal epigenetic sequencing assay (MESA) for colon cancer detection.
Read MoreGeneoscopy announced results of a clinical trial evaluating the efficacy of its home test to detect colorectal cancer and advanced adenomas.
Read MoreGuardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MoreAn analysis of more than 100,000 colorectal cancer cases uncovered hundreds of signals that may serve as new prevention targets.
Read MoreThe new findings could help clinicians better determine who’s at the highest risk for colorectal cancer so they can receive early screening.
Read More